Bolar Under Investigation: Bolar Pharmaceutical Co. is...

Bolar Under Investigation: Bolar Pharmaceutical Co. is under criminal investigation for allegedly submitting false information to the Food and Drug Administration about two generic drugs, company officials confirmed. The inspector general at the Department of Health and Human Services is conducting a criminal investigation concerning Bolar’s versions of Dyazide, a high-blood pressure drug, and Macrodantin, used to treat urinary tract infections. The company allegedly switched its product for the original drug in product safety tests and submitted the results to the FDA to win approval for its drug.